フォロー
Miquel Duran-Frigola
Miquel Duran-Frigola
Ersilia Open Source Initiative
確認したメール アドレス: ersilia.io - ホームページ
タイトル
引用先
引用先
A reference map of the human binary protein interactome
K Luck, DK Kim, L Lambourne, K Spirohn, BE Begg, W Bian, R Brignall, ...
Nature 580 (7803), 402-408, 2020
10832020
Widespread expansion of protein interaction capabilities by alternative splicing
X Yang, J Coulombe-Huntington, S Kang, GM Sheynkman, T Hao, ...
Cell 164 (4), 805-817, 2016
5992016
Systems analysis of intracellular pH vulnerabilities for cancer therapy
E Persi, M Duran-Frigola, M Damaghi, WR Roush, P Aloy, JL Cleveland, ...
Nature communications 9 (1), 2997, 2018
3822018
Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker
M Duran-Frigola, E Pauls, O Guitart-Pla, M Bertoni, V Alcalde, D Amat, ...
Nature Biotechnology 38 (9), 1087-1096, 2020
142*2020
Bioactivity descriptors for uncharacterized chemical compounds
M Bertoni, M Duran-Frigola, P Badia-i-Mompel, E Pauls, M Orozco-Ruiz, ...
Nature Communications 12 (1), 3932, 2021
702021
Isolation of human colon stem cells using surface expression of PTK7
P Jung, C Sommer, FM Barriga, SJ Buczacki, X Hernando-Momblona, ...
Stem Cell Reports 5 (6), 979-987, 2015
692015
Analysis of chemical and biological features yields mechanistic insights into drug side effects
M Duran-Frigola, P Aloy
Chemistry & biology 20 (4), 594-603, 2013
612013
Drug sensitivity in cancer cell lines is not tissue-specific
S Jaeger, M Duran-Frigola, P Aloy
Molecular cancer 14, 1-4, 2015
562015
Residues coevolution guides the systematic identification of alternative functional conformations in proteins
P Sfriso, M Duran-Frigola, R Mosca, A Emperador, P Aloy, M Orozco
Structure 24 (1), 116-126, 2016
552016
Recycling side-effects into clinical markers for drug repositioning
M Duran-Frigola, P Aloy
Genome Medicine 4 (1), 1-4, 2012
552012
Structural systems pharmacology: the role of 3D structures in next-generation drug development
M Duran-Frigola, R Mosca, P Aloy
Chemistry & biology 20 (5), 674-684, 2013
542013
Integrating and formatting biomedical data as pre-calculated knowledge graph embeddings in the Bioteque
A Fernández-Torras, M Duran-Frigola, M Bertoni, M Locatelli, P Aloy
Nature communications 13 (1), 5304, 2022
502022
Connecting chemistry and biology through molecular descriptors
A Fernández-Torras, A Comajuncosa-Creus, M Duran-Frigola, P Aloy
Current Opinion in Chemical Biology 66, 102090, 2022
492022
A community challenge for a pancancer drug mechanism of action inference from perturbational profile data
EF Douglass, RJ Allaway, B Szalai, W Wang, T Tian, A Fernández-Torras, ...
Cell Reports Medicine 3 (1), 2022
492022
First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa
G Turon, J Hlozek, JG Woodland, A Kumar, K Chibale, M Duran-Frigola
Nature Communications 14 (1), 5736, 2023
472023
Detecting similar binding pockets to enable systems polypharmacology
M Duran-Frigola, L Siragusa, E Ruppin, X Barril, G Cruciani, P Aloy
PLOS Computational Biology 13 (6), e1005522, 2017
432017
Causes of death among infants and children in the child health and mortality prevention surveillance (CHAMPS) network
Q Bassat, DM Blau, IU Ogbuanu, S Samura, E Kaluma, IA Bassey, S Sow, ...
JAMA network open 6 (7), e2322494-e2322494, 2023
422023
Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization
G Moncunill, A Scholzen, M Mpina, A Nhabomba, AB Hounkpatin, ...
Science translational medicine 12 (543), eaay8924, 2020
392020
A reference map of the human protein interactome
K Luck, DK Kim, L Lambourne, K Spirohn, BE Begg, W Bian, R Brignall, ...
BioRxiv, 605451, 2019
352019
Systems-Wide Prediction of Enzyme Promiscuity Reveals a New Underground Alternative Route for Pyridoxal 5’-Phosphate Production in E. coli
MA Oberhardt, R Zarecki, L Reshef, F Xia, M Duran-Frigola, R Schreiber, ...
PLoS computational biology 12 (1), e1004705, 2016
352016
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20